&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-01-22, 20:00

Kids Help Phone Launches acceleratorKHP Globally during Davos 2025

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-01-20, 19:07

Deriv recognised as “Most Innovative Broker - MEA 2025”
Kristofer Henninger

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2025-01-15, 22:00

STAR Systems International Acquires V Track ID to Propel Innovation in Tolling Industry

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-11-12, 21:15

Aptean Unveils Aptean AppCentral: A Revolutionary AI-Embedded Platform Enabling Businesses to Scale and Grow
Jamal Emanuel

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-10-30, 17:30

XPENG Now on Fortune China's "Tech 50" and "China 500" Lists

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-09-24, 22:24

At the Yacht Club de Monaco a promising future in the ecological and economic transition of yachting

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-06-11, 01:33

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-06-11, 01:33

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024
Capemenoneise

Notified -

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-05-22, 12:36

MetaHomes Celebrates Art and Innovation with World-Renowned Light Painting Artist, Roy Wang

&#x/blog/globe-newswire/templates/topreviews_v1/dleimages/no_icon.gif; 2024-04-15, 19:00

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

Popular Posts